US Stocks
BCLI
Brainstorm Cell Therapeutics Inc.
$0.6800
+0.0300 (+4.62%)
Volume:
711 ($483.48)
Market Capitalization:
-
Brainstorm Cell Therapeutics Price Chart
Brainstorm Cell Therapeutics Volume Chart
Brainstorm Cell Therapeutics Market Segments
Regular Trading Hours
+0.0600(+9.68%)
| Open | $0.6200 |
|---|---|
| Close | $0.6800 |
| Low | $0.6200 |
| Low Change | 0.0000 (0.00%) |
| High | $0.6800 |
| High Change | +0.0600 (+9.68%) |
| Range | $0.0600 |
| Volume | 711 |
| Dollar Volume | $483.48 |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.0300(+4.84%)
| Open | $0.6200 |
|---|---|
| Close | $0.6500 |
| Low | $0.6200 |
| Low Change | 0.0000 (0.00%) |
| High | $0.6697 |
| High Change | +0.0497 (+8.02%) |
| Range | $0.0497 |
| Volume | 1.762K |
| Dollar Volume | $1.15K |
Premarket Yesterday
*No Trades in Segment
Brainstorm Cell Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.6537 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.7222 |
| 20 Day Moving Average (SMA20) | $0.7993 |
| 50 Day Moving Average (SMA50) | $0.7947 |
| 100 Day Moving Average (SMA100) | $0.6867 |
| 200 Day Moving Average (SMA200) | $0.6889 |
Brainstorm Cell Therapeutics Statistics
| Average Volume (30 Days) | 11.14K |
|---|---|
| P/E Ratio (Current) | -.57 |
| EPS (Current) | -$1.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.10 |
| Current Ratio | 0.18 |
| Quick Ratio | 0.18 |
| Debt to Equity | -0.02 |
| Enterprise Value | $5.77M |
| EV to EBITDA | -0.49 |
| EV to Sales | — |
| Price to Book | -1.07 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -4.46% |
| Return on Equity | 1.89% |
Brainstorm Cell Therapeutics Stock Splits
There have been 2 stock splits for Brainstorm Cell Therapeutics (BCLI). The last reverse stock split occured on October 1, 2024 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Oct 1, 2024 | Reverse | 15:1 |
| Sep 16, 2014 | Reverse | 15:1 |
Brainstorm Cell Therapeutics Dividends
There have been no dividends for Brainstorm Cell Therapeutics (BCLI).